Antisecretory and anti-ulcer effects of morphine in rats after gastric mucosal aggression.
The effects of morphine on gastric secretion, barrier mucus and mucosal lesions were studied in pylorus-ligated rats treated with the ulcerogenic agents, indomethacin, aspirin or taurocholic acid. All three ulcerogenic agents induced significant mucosal lesions. Morphine decreased gastric acid secretion and suppressed the aspirin- and taurocholic acid-induced, but not the indomethacin-induced mucosal lesions. These results suggest that the ulcerogenic mechanisms of indomethacin and the other agents are not identical. Moreover the antiulcer effect of morphine appears to be mediated by an increased barrier mucus level: the amount of Alcian blue bound to the mucosa, an indirect estimate of the adherent mucus layer, was increased by morphine and correlated with its protective effect. All morphine effects were reversed by naloxone.
Tazi-Saad
K
K
INSERM U329, Faculté de Médecine Xavier Bichat, Paris, France.
Chariot
J
J
Vatier
J
J
Del Tacca
M
M
Rozé
C
C
D000818:Animals; D001241:Aspirin; D003864:Depression, Chemical; D005744:Gastric Acid / Q000378:metabolism*; D005753:Gastric Mucosa / Q000378:metabolism; D007213:Indomethacin; D008297:Male; D009020:Morphine / Q000037:antagonists & inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D009093:Mucus / Q000378:metabolism; D009270:Naloxone / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D013276:Stomach Ulcer / Q000139:chemically induced / Q000188:drug therapy*; D013656:Taurocholic Acid
D009270:Naloxone; D013656:Taurocholic Acid; D009020:Morphine; D001241:Aspirin; D007213:Indomethacin